Chemed Operating Expenses 2012-2026 | CHE
Chemed annual/quarterly operating expenses history and growth rate from 2012 to 2026. Operating expenses can be defined as the sum of all operating expenses for the given industry.
- Chemed operating expenses for the quarter ending March 31, 2026 were $0.573B, a 3.76% increase year-over-year.
- Chemed operating expenses for the twelve months ending March 31, 2026 were $2.212B, a 5.35% increase year-over-year.
- Chemed annual operating expenses for 2025 were $2.192B, a 6.15% increase from 2024.
- Chemed annual operating expenses for 2024 were $2.065B, a 7.33% increase from 2023.
- Chemed annual operating expenses for 2023 were $1.924B, a 7.39% increase from 2022.
|
Chemed Annual Operating Expenses (Millions of US $) |
|
|---|---|
| 2025 | $2,192 |
| 2024 | $2,065 |
| 2023 | $1,924 |
| 2022 | $1,791 |
| 2021 | $1,796 |
| 2020 | $1,690 |
| 2019 | $1,681 |
| 2018 | $1,539 |
| 2017 | $1,554 |
| 2016 | $1,398 |
| 2015 | $1,359 |
| 2014 | $1,288 |
| 2013 | $1,280 |
| 2012 | $1,274 |
| 2011 | $1,202 |
|
Chemed Quarterly Operating Expenses (Millions of US $) |
|
|---|---|
| 2026-03-31 | $573 |
| 2025-12-31 | $539 |
| 2025-09-30 | $550 |
| 2025-06-30 | $551 |
| 2025-03-31 | $552 |
| 2024-12-31 | $526 |
| 2024-09-30 | $514 |
| 2024-06-30 | $508 |
| 2024-03-31 | $517 |
| 2023-12-31 | $475 |
| 2023-09-30 | $478 |
| 2023-06-30 | $484 |
| 2023-03-31 | $487 |
| 2022-12-31 | $465 |
| 2022-09-30 | $446 |
| 2022-06-30 | $439 |
| 2022-03-31 | $441 |
| 2021-12-31 | $443 |
| 2021-09-30 | $446 |
| 2021-06-30 | $461 |
| 2021-03-31 | $447 |
| 2020-12-31 | $390 |
| 2020-09-30 | $454 |
| 2020-06-30 | $409 |
| 2020-03-31 | $436 |
| 2019-12-31 | $445 |
| 2019-09-30 | $416 |
| 2019-06-30 | $408 |
| 2019-03-31 | $413 |
| 2018-12-31 | $390 |
| 2018-09-30 | $382 |
| 2018-06-30 | $384 |
| 2018-03-31 | $383 |
| 2017-12-31 | $372 |
| 2017-09-30 | $363 |
| 2017-06-30 | $454 |
| 2017-03-31 | $364 |
| 2016-12-31 | $350 |
| 2016-09-30 | $350 |
| 2016-06-30 | $352 |
| 2016-03-31 | $346 |
| 2015-12-31 | $349 |
| 2015-09-30 | $336 |
| 2015-06-30 | $337 |
| 2015-03-31 | $336 |
| 2014-12-31 | $329 |
| 2014-09-30 | $318 |
| 2014-06-30 | $319 |
| 2014-03-31 | $322 |
| 2013-12-31 | $309 |
| 2013-09-30 | $312 |
| 2013-06-30 | $331 |
| 2013-03-31 | $328 |
| 2012-12-31 | $323 |
| 2012-09-30 | $318 |
| 2012-06-30 | $315 |
| 2012-03-31 | $318 |
| 2011-12-31 | $304 |
| 2011-09-30 | $300 |
| 2011-06-30 | $298 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $5.639B | $2.530B |
| Chemed Corporation purchases, operates and divests subsidiaries engaged in diverse business activities. The company's operating businesses are managed on a decentralized basis. Chemed currently operates as two wholly-owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS Healthcare segment provides hospice and palliative care services for patients with terminal illnesses. VITAS offer all levels of hospice care in a given market, including routine home care, inpatient care and continuous care. Roto-Rooter segment provides plumbing and drain-cleaning services to both residential and commercial customers. It provides repair and maintenance services to residential and commercial accounts using the Roto-Rooter registered service marks. Such services include plumbing and sewer, drain and pipe cleaning. They are delivered through company-owned and operated territories, independent contractor-operated territories and franchised locations. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |